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Advancing Research and Development on 
Live Microorganisms for the Promotion of 
Human Health
The human body is colonized by trillions of mi-
crobes, collectively referred to as the endoge-
nous microbiota. These microorganisms protect 
us against pathogens and promote wellbeing, but 
when the microbiota is disrupted it becomes a risk 
factor for disease and frailty. Intervention with cer-
tain benefi cial microbes may restore alterations of 
the microbiota composition, and thereby reduce 
the risk of disease and advance human health. 
These benefi cial microbes are called ‘probiotics’ 
(for life) and fuel a multi-billion-dollar market that 
benefi ts healthy consumers and patients globally. 
In recent years, however, it became increasingly 
evident that the innovation process for probiotics 
is hampered considerably, since probiotics are 
not consistently used in clinical practice, no (Euro-
pean) health claim has been approved to date and 
there remains a lack of fundamental knowledge 
on probiotics and their interaction with the host. 
As this curtails the therapeutic and socioeconom-
ic potential of probiotics for consumers and pa-
tients, this thesis sets out study persistent barriers 
to the probiotic innovation process to advance re-
search & development on live microorganisms for 
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